Characteristics | n = 26 |
---|---|
Gender | |
 Male | 20 (77%) |
 Female | 6 (23%) |
Age (years) | Â |
 Median | 52 |
 Range | 38–77 |
Clinical stage | |
 T2 | 5 (19%) |
 T3 | 16 (62%) |
 T4 | 5 (19%) |
 N1–2 | 23 (88%) |
Distance (cm) from anal verge | |
 Median | 7 |
 Low (0–5) | 10 |
 Mid (> 5–10) | 11 |
 High (> 10–15) | 5 |
Doses* of neoadjuvant chemotherapy | |
 Median | 4 |
 Range | 3–8 |
Surgery | Â |
 Surgical resection | 20 (77%) |
 Non-operative management/watch-and-wait | 6 (23%) |